Real-time enrollment status for this b-cell lymphoma clinical trial
Current Status
Terminated
Checked: April 18, 2026 at 12:24 AM UTC
| NCT Number | NCT06088654 |
| Recruiting Status | Terminated |
| Condition | B-Cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 184 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Innate Pharma |
| Last Updated on CT.gov | April 14, 2026 (4 days ago) |
As of April 18, 2026: Clinical trial NCT06088654 is currently terminated participants. This clinical trial study for b-cell lymphoma is not currently accepting new participants at 5 locations across the United States. The study is sponsored by Innate Pharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06088654 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06088654 was last updated 4 days ago (April 14, 2026). HelloStudys verifies this status automatically.